Meeting
Abstract Number: 466
SHM Converge 2024
Case Presentation: A 91-year-old male with a known history of benign prostatic hyperplasia (BPH), diastolic heart failure, pulmonary embolism, hypertension, and previous extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli (E. coli) urinary tract infection (UTI) presented with encephalopathy. He was not tachypneic nor tachycardic, but his bicarbonate was low at less than 8, and his lactic acid […]
Abstract Number: 676
SHM Converge 2024
Case Presentation: In September 2021, a 53-year-old male with a BMI of 30.91 and no history of alcohol use was diagnosed with advanced prostate cancer, indicated by a PSA level of 111. A transrectal ultrasound-guided prostate biopsy revealed Gleason score 4+5 prostate adenocarcinoma. In February 2022, the patient initiated treatment with Androgen Deprivation Therapy (ADT) […]
Abstract Number: 748
SHM Converge 2024
Case Presentation: An 86-year-old male patient with a history of hypertension and newly diagnosed stage 2 prostate cancer was referred from the cancer center due to a hypertensive emergency following the administration of a leuprolide injection. Shortly after receiving the first leuprolide injection, the patient experienced facial flushing, ocular pain, a sensation of eyes bulging […]
Abstract Number: 751
SHM Converge 2024
Case Presentation: A 74-year-old individual, a heavy smoker, was diagnosed with advanced Stage III prostate cancer and subsequently underwent androgen deprivation therapy coupled with radiotherapy. Two years later, during active surveillance, the patient experienced exertional dyspnea, prompting a chest CT scan. The scan revealed two significant findings: a complete occlusion of the right upper lobe […]